Comparison between the census-based and the insurance-based explanatory models for the SML and GWR cases. by Lorenzo Donadio (10224566)

Suppl Figs for Malysz et al TRPM4 channel inhibitors AJP Cell by John Malysz (6858848)

Distribution of number of articles according to years in the OA-ePMC set. by Şenay Kafkas (416311)

Commonly existing OTUs among the treatments with different electron donor amendments. by Meiying Xu (186371)

Field Images of plot design showing pictures of before the treatment and effects after the treatment. by Binayak Raj Pandey (4545145)

(Facebook) percentage changes in terms of engagement with posts. by Matteo Cinelli (8575176)

Verification of accuracy degradation by error-containing teacher data. by Kenshiro Nishida (5843192)

Prevalence of asthma according to age. by Joo Hyun Lim (4471519)

DataSheet_1_ENSO coupling to the equatorial Atlantic: Analysis with an extended improved recharge oscillator model.pdf by Rodrigo Crespo-Miguel (14422728)

“…Moreover, the damping time of the ENSO fluctuations has doubled from 10 to 20 months, and the oscillation period of ENSO has decreased from 60-70 months before the 1960s to 50 months afterward. …”

MicroRNA-4290 suppresses PDK1-mediated glycolysis to enhance the sensitivity of gastric cancer cell to cisplatin by Yan Qian (388125)

“…Moreover, miR-4290 significantly inhibited glycolysis and decreased the IC50 value to cisplatin in SGC7901 cells, whereas these effects were abolished and cell apoptosis was promoted when PDK1 was overexpressed. …”

Biological processes unaffected by aminoguanidine treatment, histological analyses with thorough pathologist evaluation, and primers used in PCR experiments by CONSUELO PASTEN (22493195)

“…To explore its clinical relevance, we evaluated whether AG could also reduce kidney damage when administered <b>after</b> ischemia. …”

Image_4_Positive Effects of Neutrophil Elastase Inhibitor (Sivelestat) on Gut Microbiome and Metabolite Profiles of Septic Rats.tif by Yali Sun (2099593)

“…</p>Results<p>Sivelestat administration significantly improved the survival of septic rats (80% vs 50%, P = 0.047). Microbiome analysis showed that the microbiota composition of rats in the CLP group was significantly disturbed, as potential pathogens such as Escherichia-Shigella and Gammaproteobacteria became dominant, and the beneficial microbiota represented by Lactobacillus decreased. …”

Image_2_Positive Effects of Neutrophil Elastase Inhibitor (Sivelestat) on Gut Microbiome and Metabolite Profiles of Septic Rats.tif by Yali Sun (2099593)

“…</p>Results<p>Sivelestat administration significantly improved the survival of septic rats (80% vs 50%, P = 0.047). Microbiome analysis showed that the microbiota composition of rats in the CLP group was significantly disturbed, as potential pathogens such as Escherichia-Shigella and Gammaproteobacteria became dominant, and the beneficial microbiota represented by Lactobacillus decreased. …”

Image_5_Positive Effects of Neutrophil Elastase Inhibitor (Sivelestat) on Gut Microbiome and Metabolite Profiles of Septic Rats.tif by Yali Sun (2099593)

“…</p>Results<p>Sivelestat administration significantly improved the survival of septic rats (80% vs 50%, P = 0.047). Microbiome analysis showed that the microbiota composition of rats in the CLP group was significantly disturbed, as potential pathogens such as Escherichia-Shigella and Gammaproteobacteria became dominant, and the beneficial microbiota represented by Lactobacillus decreased. …”

Image_3_Positive Effects of Neutrophil Elastase Inhibitor (Sivelestat) on Gut Microbiome and Metabolite Profiles of Septic Rats.tif by Yali Sun (2099593)

“…</p>Results<p>Sivelestat administration significantly improved the survival of septic rats (80% vs 50%, P = 0.047). Microbiome analysis showed that the microbiota composition of rats in the CLP group was significantly disturbed, as potential pathogens such as Escherichia-Shigella and Gammaproteobacteria became dominant, and the beneficial microbiota represented by Lactobacillus decreased. …”

Image_1_Positive Effects of Neutrophil Elastase Inhibitor (Sivelestat) on Gut Microbiome and Metabolite Profiles of Septic Rats.tif by Yali Sun (2099593)

“…</p>Results<p>Sivelestat administration significantly improved the survival of septic rats (80% vs 50%, P = 0.047). Microbiome analysis showed that the microbiota composition of rats in the CLP group was significantly disturbed, as potential pathogens such as Escherichia-Shigella and Gammaproteobacteria became dominant, and the beneficial microbiota represented by Lactobacillus decreased. …”

Table_1_Positive Effects of Neutrophil Elastase Inhibitor (Sivelestat) on Gut Microbiome and Metabolite Profiles of Septic Rats.docx by Yali Sun (2099593)

“…</p>Results<p>Sivelestat administration significantly improved the survival of septic rats (80% vs 50%, P = 0.047). Microbiome analysis showed that the microbiota composition of rats in the CLP group was significantly disturbed, as potential pathogens such as Escherichia-Shigella and Gammaproteobacteria became dominant, and the beneficial microbiota represented by Lactobacillus decreased. …”

α-PGG inhibited ADP- or thrombin-induced lowering of cyclic AMP. by Rehana Perveen (340511)

“…ADP and thrombin decreased basal cyclic AMP levels by 24% (*p<0.03) and 22% (*p<0.02) respectively. α-PGG blocked ADP and thrombin induced decrease in cyclic AMP levels.…”

Image1_The Pore-Forming Subunit C2IIa of the Binary Clostridium botulinum C2 Toxin Reduces the Chemotactic Translocation of Human Polymorphonuclear Leukocytes.TIF by Julia Eisele (12075839)

C−C Plasticity in Boron Chemistry:  Modulation of the C_c···C_c Distance in Mixed Pyrrolyl/Dicarbollide Complexes^† by Jordi Llop (1425115)